Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model

Bibliographic Details
Title: Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model
Authors: Yamamoto, Jun, Miyake, Kentaro, Han, Qinghong, Tan, Yuying, Inubushi, Sachiko, Sugisawa, Norihiko, Higuchi, Takashi, Tashiro, Yoshihiko, Nishino, Hiroto, Homma, Yuki, Matsuyama, Ryusei, Chawla, Sant P., Bouvet, Michael, Singh, Shree Ram, Endo, Itaru, Hoffman, Robert M.
Source: In Cancer Letters 1 November 2020 492:174-184
Database: ScienceDirect
More Details
ISSN:03043835
DOI:10.1016/j.canlet.2020.07.034
Published in:Cancer Letters
Language:English